SPRY Operating Expenses

Ars Pharmaceuticals Inc · Operating Expenses

SPRY logo

SPRY Operating Expenses

Latest reported$302.67M
SPRY TTM Operating Expenses ($30.07M → $302.67M)
High-resolution chart · PNG

SPRY operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ars Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
302,669,000
278,739,000
243,303,000
212,445,000
158,647,000
109,244,000
76,098,000
47,428,000
38,700,000
43,161,000
47,484,000
52,551,000
40,601,000
29,654,000
19,712,000
9,624,000
7,620,000
6,094,000
4,687,000
15,522,000
20,560,000
24,469,000
30,073,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.